While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...

Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...

Lehigh Valley health experts discuss obesity, energy management, Medicaid changes, and GLP-1 drug trends at LVBCH’s 45th ...

Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...

GLP-1 weight loss drugs like Ozempic and Wegovy are being hailed as game-changers, but are they really safe, effective, or sustainable?

Discover the most effective foods for controlling blood sugar, improving insulin sensitivity, and potentially reversing type ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.